Abstract:Abstract Parasitic nematodes are globally important and place a heavy disease burden on infected humans, crops and livestock, while commonly administered anthelmintics used for treatment are being rendered ineffective by increasing levels of resistance. Although the modes of action and resistance mechanisms caused by detoxification and target site insensitivity for these compounds is well documented, the mechanisms for uptake, which can also cause resistance, are still poorly defined. It has recently been shown in the model nematode Caenorhabditis elegans that the avermectins or macrocyclic lactones such as ivermectin and moxidectin gain entry though the sensory cilia of the amphid neurons. This study interrogated the molecular mechanisms involved in the uptake of avermectins using a combination of forward genetics and targeted resistance screening approaches along with visualising a BODIPY labelled ivermectin analog and confirmed the importance of intraflagellar transport in this process. This approach also identified the protein trafficking pathways used by the downstream effectors and the components of the ciliary basal body that are required for effector entry into these non-motile structures. Mutations in many of the genes under investigation also resulted in resistance to the unrelated anthelmintic drugs albendazole and levamisole, giving insights into the potential mechanisms of multidrug resistance observed in field isolates of the parasitic nematodes that are a scourge of ruminant livestock. In total 50 novel C. elegans anthelmintic survival associated genes were identified in this study, three of which ( daf-6 , rab-35 and inx-19 ) are associated with broad spectrum cross resistance. When combined with previously known resistance genes, there are now 53 resistance associated genes which are directly involved in amphid, cilia and IFT function. Author Summary Nematodes represent significant pathogens of man and domestic animals and control relies heavily on limited classes of Anthelminitic drugs. Single and multi-drug resistance is a growing problem however mechanisms of anthelmintic drug resistance and drug uptake by nematodes remain to be clearly elucidated. In Caenorhabditis elegans there has been an association between amphid and dye filling defects with resistance to avermectins however the effector and causal mechanisms remain elusive. This study uses a combination of fluorescently labelled anthelmintics and anthelmintic resistance screens to probe the uptake mechanisms for these drugs. The role of the sensory amphids in the uptake of avermectins was confirmed. The avermectins enter the distal segment of the cilia using an effector which is delivered by the UNC-119 and UNC-33/UNC-44 transport systems to the base of the cilia, followed by distal appendage dependent entry and transport along the cilia by the intraflagellar transport pathway. Of the genes investigated, three ( daf-6 , rab-35 and inx-19 ) were linked to cross resistance against all the anthelmintics tested (Ivermectin, Moxidectin, Albendazole and Levamisole). This study gives further insight into how important classes of anthelmintics enter nematodes and highlights the potential for this process to give rise to anthelmintic resistance.

Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity

An Extensive Comparison of the Effect of Anthelmintic Classes on Diverse Nematodes

Discovery of a Highly Synergistic Anthelmintic Combination That Shows Mutual Hypersusceptibility

Three Small Molecule Entities (MPK18, MPK334 and YAK308) with Activity against Haemonchus contortus In Vitro

An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs

In Vivo and in Vitro Studies of Cry5B and Nicotinic Acetylcholine Receptor Agonist Anthelmintics Reveal a Powerful and Unique Combination Therapy Against Intestinal Nematode Parasites

High-throughput screening of more than 30,000 compounds for anthelmintics against gastrointestinal nematode parasites

Structure activity relationship and target prediction for ABX464 analogues in Caenorhabditis elegans

High-Throughput Phenotypic Assay to Screen for Anthelmintic Activity on Haemonchus contortus

High-Throughput Phenotypic Assay to Screen for Anthelmintic Activity on <i>Haemonchus contortus</i>

Screening of a drug repurposing library with a nematode motility assay identifies promising anthelmintic hits against Cooperia oncophora and other ruminant parasites

Effective drug combination for Caenorhabditis elegans nematodes discovered by output-driven feedback system control technique

Structure-activity relationship and target investigation of 2-aryl quinolines with nematocidal activity

Comparative Structure Activity and Target Exploration of 1,2-Diphenylethynes in Haemonchus Contortus and Caenorhabditis Elegans

The relationship between intraflagellar transport and upstream protein trafficking pathways and macrocyclic lactone resistance in Caenorhabditis elegans

Natural Products Are a Promising Source for Anthelmintic Drug Discovery

A microfluidic device for whole-animal drug screening using electrophysiological measures in the nematode C. elegans

High-Throughput Screening of Entamoeba Identifies Compounds Which Target Both Life Cycle Stages and Which Are Effective Against Metronidazole Resistant Parasites

Screening of the 'open Scaffolds' Collection from Compounds Australia Identifies a New Chemical Entity with Anthelmintic Activities Against Different Developmental Stages of the Barber's Pole Worm and Other Parasitic Nematodes.

Integrating metabolomics into the diagnosis and investigation of anthelmintic resistance

The uptake of avermectins in Caenorhabditis elegans is dependent on Intra-Flagellar Transport and other protein trafficking pathways